The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 24, 2023 | Appelhans Dannielle | CEO and President | Sell(S) | 10K | $0.13 | $1K |
| Feb 1, 2023 | Appelhans Dannielle | CEO and President | Sell(S) | 4K | $0.25 | $970 |
| Feb 1, 2023 | Cagnoni Pablo J | Director | Sell(S) | 8K | $0.25 | $2K |
| Jan 31, 2023 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 9K | — | — |
| Jan 31, 2023 | Turka Laurence A. | Chief Scientific Officer | Sell(S) | 3K | $0.24 | $622 |
| Jan 31, 2023 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 9K | — | $0 |
| Jan 31, 2023 | Cagnoni Pablo J | Director | Option exercise(M) | 25K | — | — |
| Jan 31, 2023 | Cagnoni Pablo J | Director | Sell(S) | 7K | $0.24 | $2K |
| Jan 31, 2023 | Cagnoni Pablo J | Director | Option exercise(M) | 25K | — | $0 |
| Jan 31, 2023 | Appelhans Dannielle | CEO and President | Option exercise(M) | 8K | — | — |
| Jan 31, 2023 | Appelhans Dannielle | CEO and President | Option exercise(M) | 8K | — | $0 |
| Jan 29, 2023 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 7K | — | — |
| Jan 29, 2023 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Jan 29, 2023 | Cagnoni Pablo J | Director | Option exercise(M) | 21K | — | — |
| Jan 29, 2023 | Cagnoni Pablo J | Director | Option exercise(M) | 21K | — | $0 |
| Aug 10, 2022 | Appelhans Dannielle | Chief Operating Officer | Sell(S) | 6K | $0.80 | $5K |
| Aug 9, 2022 | Appelhans Dannielle | Chief Operating Officer | Option exercise(M) | 13K | — | — |
| Aug 9, 2022 | Appelhans Dannielle | Chief Operating Officer | Option exercise(M) | 13K | — | $0 |
| Jul 29, 2022 | Schaffert Susanne | Director | Grant(A) | 50K | — | $0 |
| May 12, 2022 | Epstein David R | Director | Grant(A) | 500K | — | $0 |
| May 12, 2022 | Symonds Jonathan | Director | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Afeyan Noubar | Director, 10% Owner | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Sohn Catherine A. | Director | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Rosenblatt Michael | Director | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Cuss Francis M | Director | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Holles Natalie C. | Director | Grant(A) | 25K | — | $0 |
| May 12, 2022 | Prener Anne | Director | Grant(A) | 25K | — | $0 |
| Apr 21, 2022 | Epstein David R | Director | Buy(P) | 30K | $1.44 | $43K |
| Feb 1, 2022 | Turka Laurence A. | Chief Scientific Officer | Sell(S) | 3K | $6.57 | $17K |
| Feb 1, 2022 | Keson-Brookes Maiken | CLO & Corp. Secretary | Sell(S) | 3K | $6.57 | $18K |
| Feb 1, 2022 | Cagnoni Pablo J | CEO and President, Director | Sell(S) | 7K | $6.57 | $44K |
| Jan 31, 2022 | Turka Laurence A. | Chief Scientific Officer | Grant(A) | 35K | — | $0 |
| Jan 31, 2022 | Turka Laurence A. | Chief Scientific Officer | Grant(A) | 144K | — | $0 |
| Jan 31, 2022 | Keson-Brookes Maiken | CLO & Corp. Secretary | Grant(A) | 144K | — | $0 |
| Jan 31, 2022 | Keson-Brookes Maiken | CLO & Corp. Secretary | Grant(A) | 35K | — | $0 |
| Jan 31, 2022 | Appelhans Dannielle | Chief Operating Officer | Grant(A) | 125K | — | $0 |
| Jan 31, 2022 | Appelhans Dannielle | Chief Operating Officer | Grant(A) | 30K | — | $0 |
| Jan 31, 2022 | Carmona Jose | Chief Financial Officer | Grant(A) | 35K | — | $0 |
| Jan 31, 2022 | Carmona Jose | Chief Financial Officer | Grant(A) | 144K | — | $0 |
| Jan 31, 2022 | Cagnoni Pablo J | CEO and President, Director | Grant(A) | 100K | — | $0 |
| Jan 31, 2022 | Cagnoni Pablo J | CEO and President, Director | Grant(A) | 365K | — | $0 |
| Jan 29, 2022 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 7K | — | — |
| Jan 29, 2022 | Turka Laurence A. | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Jan 29, 2022 | Keson-Brookes Maiken | CLO & Corp. Secretary | Option exercise(M) | 8K | — | — |
| Jan 29, 2022 | Keson-Brookes Maiken | CLO & Corp. Secretary | Option exercise(M) | 8K | — | $0 |
| Jan 29, 2022 | Cagnoni Pablo J | CEO and President, Director | Option exercise(M) | 21K | — | — |
| Jan 29, 2022 | Cagnoni Pablo J | CEO and President, Director | Option exercise(M) | 21K | — | $0 |
| Aug 31, 2021 | Appelhans Dannielle | Chief Operating Officer | Grant(A) | 150K | — | $0 |
| Aug 31, 2021 | Appelhans Dannielle | Chief Operating Officer | Grant(A) | 50K | — | $0 |
| May 12, 2021 | Prener Anne | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Holles Natalie C. | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Cuss Francis M | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Rosenblatt Michael | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Sohn Catherine A. | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Afeyan Noubar | Director, 10% Owner | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Symonds Jonathan | Director | Grant(A) | 25K | — | $0 |
| May 12, 2021 | Epstein David R | Director | Grant(A) | 28K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).